Trial Profile
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary) ; Rifampicin (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 26 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2005 New trial record.